HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna V Galkin Selected Research

CVS-3983

11/2004CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna V Galkin Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
04/2006 - 11/2004
1Adenocarcinoma
01/2011
1Lymphoma (Lymphomas)
01/2007
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2007
1Carcinogenesis
04/2006
1Disease Progression
04/2006
1Neoplasms (Cancer)
11/2004
1Carcinoma (Carcinomatosis)
11/2004

Drug/Important Bio-Agent (IBA)

2AndrogensIBA
04/2006 - 11/2004
1CateninsIBA
01/2011
1p80(NPM-ALK) proteinIBA
01/2007
1NVP-TAE684IBA
01/2007
1Pyridinolcarbamate (P23)IBA
01/2007
1VA 061 (VA061)IBA
04/2006
1Raloxifene Hydrochloride (Evista)FDA Link
04/2006
1CVS-3983IBA
11/2004
1matriptaseIBA
11/2004
1Proteins (Proteins, Gene)FDA Link
11/2004
1Serine Proteases (Serine Protease)IBA
11/2004
1RNA (Ribonucleic Acid)IBA
11/2004

Therapy/Procedure

1Therapeutics
04/2006